Skip to content
← Full study record

NCT00281840 · MORE INFO

Limitations, agreements, and source contact

Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer · Source last updated 2015-06-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
Panayiotis.Savvides@uhhospitals.org
organization
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
phone
216-844-5946
title
Panayiotis Savvides, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
Panayiotis.Savvides@uhhospitals.org
organization
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
phone
216-844-5946
title
Panayiotis Savvides, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice